Pilar Huerta Ph.D

Pilar Huerta Ph.D General Information

Biography

Dr. Pilar Huerta serves as Board Member at Vaxdyn. She served as Chief Executive Officer at ADL Bionatur Solutions and ADL Biopharma. She served as Chief Executive Officer & Chief Financial Officer at Sygnis. She has accumulated an extensive experience in the pharma and biotech sector over the last 15 years. She joined Genetrix group as a CEO in 2010, moving to SYGNIS after the merger between Xpol, Genetrix subsidiary and SYGNIS AG in October 2012. From 2006 to 2010, she was a strategic consultant within several companies, such as Viamed Salud Group, where she was responsible for R&D and New Business and was appointed CEO of the two most innovative companies within the Group: Araclon Biotech, SL. and Viamed Technology Investments. Before that, she was CEO at Neuropharma (Noscira, Zeltia Group) and assumed various responsibilities within the Zeltia Group, (the biggest quoted biotech holding in Spain). She holds a Bachelor's Degree in Business and Administration from the UCM and has completed the IESE's Advanced Management Program (AMP) and Program for Management Development (PMD) courses at Navarra University. She has been appointed as a board member of several Spanish companies during the last 10 years but has left most of them to dedicate her time 100% to the new SYGNIS. Currently, she is part of the management board of SYGNIS. She holds a Master's Degree in Business and Administration from the UCM. IESE's Advanced Management Program (AMP) and Program for Management Development (PMD) from the University of Navarra.